Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Uptake of pneumococcal polysaccharide vaccination among working-age adults with underlying medical conditions, United States, 2009.

Lu PJ, Nuorti JP.

Am J Epidemiol. 2012 Apr 15;175(8):827-37. doi: 10.1093/aje/kwr376. Epub 2012 Mar 8.

PMID:
22403807
2.

Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23).

Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices.

MMWR Morb Mortal Wkly Rep. 2010 Sep 3;59(34):1102-6.

3.

Pneumococcal polysaccharide vaccination among adults aged 65 years and older, U.S., 1989-2008.

Lu PJ, Nuorti JP.

Am J Prev Med. 2010 Oct;39(4):287-95. doi: 10.1016/j.amepre.2010.06.004.

PMID:
20837278
4.

The epidemiologic evidence underlying recommendations for use of pneumococcal polysaccharide vaccine among American Indian and Alaska Native populations.

Said MA, O'Brien KL, Nuorti JP, Singleton R, Whitney CG, Hennessy TW.

Vaccine. 2011 Jul 26;29(33):5355-62. doi: 10.1016/j.vaccine.2011.05.086. Epub 2011 Jun 12.

PMID:
21664217
5.

Influenza and pneumococcal vaccination coverage among persons aged > or =65 years and persons aged 18-64 years with diabetes or asthma--United States, 2003.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2004 Nov 5;53(43):1007-12. Erratum in: MMWR Morb Mortal Wkly Rep. 2005 Sep 23;54(37):935.

6.

Hepatitis B vaccination coverage among high-risk adults 18-49 years, U.S., 2009.

Lu PJ, Byrd KK, Murphy TV, Weinbaum C.

Vaccine. 2011 Sep 16;29(40):7049-57. doi: 10.1016/j.vaccine.2011.07.030. Epub 2011 Jul 22.

PMID:
21782873
7.

Preventability of invasive pneumococcal disease and assessment of current polysaccharide vaccine recommendations for adults: United States, 2001-2003.

Greene CM, Kyaw MH, Ray SM, Schaffner W, Lynfield R, Barrett NL, Long C, Gershman K, Pilishvili T, Roberson A, Zell ER, Whitney CG, Bennett NM; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network.

Clin Infect Dis. 2006 Jul 15;43(2):141-50. Epub 2006 Jun 9.

PMID:
16779739
9.

Influenza vaccination among adults with asthma findings from the 2007 BRFSS survey.

Lu PJ, Euler GL, Callahan DB.

Am J Prev Med. 2009 Aug;37(2):109-15. doi: 10.1016/j.amepre.2009.03.021.

PMID:
19589448
10.
11.

Adults with invasive pneumococcal disease: missed opportunities for vaccination.

Kyaw MH, Greene CM, Schaffner W, Ray SM, Shapiro M, Barrett NL, Gershman K, Craig AS, Roberson A, Zell ER, Schuchat A, Bennett NM, Whitney CG; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network.

Am J Prev Med. 2006 Oct;31(4):286-92. Epub 2006 Aug 22.

PMID:
16979452
12.

Pharmacists as providers: targeting pneumococcal vaccinations to high risk populations.

Taitel M, Cohen E, Duncan I, Pegus C.

Vaccine. 2011 Oct 19;29(45):8073-6. doi: 10.1016/j.vaccine.2011.08.051. Epub 2011 Aug 22.

14.

Influenza vaccination coverage among persons with asthma--United States, 2005-06 influenza season.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2008 Jun 20;57(24):653-7.

15.

Higher pneumococcal disease vaccination rates needed to protect more at-risk US adults.

Rehm SJ, Farley MM, File TM Jr, Hall WJ, Hopkins R, Levine OS, Nichol KL, Nuorti P, Zimmerman RK, Schaffner W.

Postgrad Med. 2009 Nov;121(6):101-5. doi: 10.3810/pgm.2009.11.2069.

PMID:
19940420
16.

Addressing Pneumococcal Vaccine Uptake Disparities among African-American Adults in the United States.

Fry CA, Silverman EP, Miller S.

Public Health Nurs. 2016 Jul;33(4):277-82. doi: 10.1111/phn.12257. Epub 2016 Apr 22.

PMID:
27103181
17.

State-specific prevalence of selected chronic disease-related characteristics--Behavioral Risk Factor Surveillance System, 2001.

Ahluwalia IB, Mack KA, Murphy W, Mokdad AH, Bales VS.

MMWR Surveill Summ. 2003 Aug 22;52(8):1-80.

18.

Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Kobayashi M, Bennett NM, Gierke R, Almendares O, Moore MR, Whitney CG, Pilishvili T.

MMWR Morb Mortal Wkly Rep. 2015 Sep 4;64(34):944-7. doi: 10.15585/mmwr.mm6434a4. Erratum in: MMWR Morb Mortal Wkly Rep. 2015 Oct 30;64(42):1204.

19.

Hepatitis A vaccination coverage among adults aged 18-49 years in the United States.

Lu PJ, Euler GL, Hennessey KA, Weinbaum CM.

Vaccine. 2009 Feb 25;27(9):1301-5. doi: 10.1016/j.vaccine.2008.12.054. Epub 2009 Jan 20.

PMID:
19162116
20.

Supplemental Content

Support Center